普里斯蒂米林通过改善PPARα通路来保护病态心脏缩
Ye Lu1, Zhaoxiang Zeng2, Xianhao Bao2
1Department of Interventional Center and Vascular Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China; Department of Vascular Surgery, Changhai Hospital, Navy Medical University, Shanghai, PR China.
Toxicology and applied pharmacology
|June 3, 2023
概括
普里斯蒂米林 (PM) 通过改善PPARα/PGC1通路来保护病态心脏缩. 这种天然化合物可以减少心脏功能障碍,缩和纤维化,提供一种潜在的治疗策略.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
背景情况:
- 普里斯蒂米林 (PM) 是来自塞拉斯特拉和希波克拉特科的天然化合物,显示出药理学潜力,特别是抗癌作用.
- 在病理性心脏缩中PM的作用,这是一种以心肌扩大为特征的疾病,仍然在很大程度上是未知的.
- 了解PM对心脏缩的影响对于开发新型治疗干预措施至关重要.
研究的目的:
- 研究普里斯蒂米林 (PM) 对压力过载诱导的病态心脏缩的保护作用.
- 阐明潜在的分子通路,特别是PPARα/PGC1信号通路的作用.
- 评估PM在体内小鼠模型和体外新生儿大鼠心肌细胞模型中的疗效.
主要方法:
- 通过横向大动脉收缩 (TAC) 或异二醇 (ISO) 管理心脏缩的已建立的小鼠模型.
- 给小鼠注射PM (0.5 mg/Kg/d) 并使用PPARα敲击小鼠进行机理学研究.
- 在新生小鼠心肌细胞 (NRCMs) 中使用 ангиотензинII (Ang II) 刺激,以评估PM对细胞缩和线粒体功能的影响.
主要成果:
- 在压力过重的小鼠中,PM显著减轻心脏功能障碍,心肌缩和纤维化.
- 在NRCM中,PM逆转了 ангиотензинII诱导的心肌细胞缩和线粒体功能障碍.
- RNA测序显示,PM的有益作用通过PPARα/PGC1通路进行介导,因为沉默PPARα取消了PM的保护作用.
结论:
- 普里斯蒂米林 (PM) 显示出对病理性心脏缩有显著的保护作用.
- 该机制涉及PPARα/PGC1信号通路的上调,增强线粒体功能和代谢基因表达.
- PM代表了治疗心脏缩的有希望的治疗候选者,需要进一步的临床研究.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
470
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
470
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K